We are live on ! Find out more
TLSA icon

Tiziana Life Sciences
TLSA

24 hedge funds and large institutions have $3.97M invested in Tiziana Life Sciences in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

4% more funds holding

Funds holding: 23 → 24 (+1)

0.67% less ownership

Funds ownership: 5.88% → 5.21% (-0.67%)

34% less capital invested

Capital invested by funds: $6.02M → $3.97M (-$2.05M)

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
5
Closed
2
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$48.2K
2
Citadel Advisors
Citadel Advisors
Florida
+$30.6K
3
ZF
Zhang Financial
Michigan
+$16.5K
4
UBS Group
UBS Group
Switzerland
+$3.92K
5
State Street
State Street
Massachusetts
+$3.1K

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$212K
2
HSBC Holdings
HSBC Holdings
United Kingdom
-$121K
3
JP Morgan Chase
JP Morgan Chase
New York
-$91K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$30K
5
VF
Virtu Financial
New York
-$16.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
HighTower Advisors
1
HighTower Advisors
Illinois
$3.08M – – –
State Street
2
State Street
Massachusetts
$240K +$3.1K +3,614 +1%
HSBC Holdings
3
HSBC Holdings
United Kingdom
$227K -$121K -140,287 -31%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$140K +$2.17K +2,528 +1%
Morgan Stanley
5
Morgan Stanley
New York
$112K +$48.2K +56,057 +59%
AFP
6
Ausdal Financial Partners
Iowa
$42K – – –
Citadel Advisors
7
Citadel Advisors
Florida
$37K +$30.6K +35,562 +255%
Bank of America
8
Bank of America
North Carolina
$20K -$16 -19 -0.1%
WAM
9
Warberg Asset Management
Illinois
$16K – – –
ZF
10
Zhang Financial
Michigan
$14K +$16.5K +19,200 New
Barclays
11
Barclays
United Kingdom
$13K – – –
VF
12
Virtu Financial
New York
$9K -$16.1K -18,740 -60%
CS
13
Credit Suisse
Switzerland
$4K -$4.41K -5,128 -48%
TRCT
14
Tower Research Capital (TRC)
New York
$4K +$2.75K +3,206 +116%
UBS Group
15
UBS Group
Switzerland
$4K +$3.92K +4,557 +522%
Citigroup
16
Citigroup
New York
$2K -$212K -246,923 -99%
Group One Trading
17
Group One Trading
Illinois
$2K – – –
IA
18
IFP Advisors
Florida
$1K – – –
Northwestern Mutual Wealth Management
19
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
BlackRock
20
BlackRock
New York
$1K +$1.42K +1,656 New
JP Morgan Chase
21
JP Morgan Chase
New York
– -$91K -86,258 Closed
Bank of Montreal
22
Bank of Montreal
Ontario, Canada
– -$30K -25,000 Closed
Osaic Holdings
23
Osaic Holdings
Arizona
– +$4 +5 New

TLSA Hedge Fund Activity: Q2 2022 in Review

24 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q2 2022, worth a combined $3.97M — down 34% from $6.02M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new TLSA positions and 2 closed out — a net gain of 1 holder — while 6 added to existing stakes and 5 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $48.2K. The largest seller was Citigroup, cutting an estimated $212K.

  • 24 institutional investors held Tiziana Life Sciences (TLSA) as of Q2 2022, up from 23 in Q1 2022.
  • Funds reported $3.97M of Tiziana Life Sciences stock for Q2 2022, down 34% quarter-over-quarter.
  • 3 funds opened new Tiziana Life Sciences positions in Q2 2022 and 2 closed out, a net change of +1 holder.
  • The largest Tiziana Life Sciences buyer in Q2 2022 was Morgan Stanley, an estimated $48.2K added.
  • The largest Tiziana Life Sciences seller in Q2 2022 was Citigroup, an estimated $212K sold.

Based on aggregated 13F filings for Q2 2022.